[go: up one dir, main page]

AR067887A1 - Composicion medica con contenido de rebamipide - Google Patents

Composicion medica con contenido de rebamipide

Info

Publication number
AR067887A1
AR067887A1 ARP080103471A ARP080103471A AR067887A1 AR 067887 A1 AR067887 A1 AR 067887A1 AR P080103471 A ARP080103471 A AR P080103471A AR P080103471 A ARP080103471 A AR P080103471A AR 067887 A1 AR067887 A1 AR 067887A1
Authority
AR
Argentina
Prior art keywords
medical composition
salt
rebamipide
content
arginine
Prior art date
Application number
ARP080103471A
Other languages
English (en)
Inventor
Nishikawa Yoshiharu
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR067887A1 publication Critical patent/AR067887A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Preparacion farmacéutica en la cual se reduce la expresion de la amargura. La composicion médica de la presente contiene rebamipide, o una sal del mismo, y L-arginina, o una sal de la misma. La forma de realizacion preferida de la composicion médica de la presente contiene rebamipide, o una sal del mismo, y L-arginina, o una sal de la misma, junto con al menos un edulcorante seleccionado del grupo que consistente en taumatina, stevia y extractos del fruto de luohan. Al agregar dicho edulcorante, es posible reducir sensiblemente la amargura atribuible al rebamipide, o a una sal del mismo, de la composicion médica.
ARP080103471A 2007-08-10 2008-08-08 Composicion medica con contenido de rebamipide AR067887A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007209284 2007-08-10

Publications (1)

Publication Number Publication Date
AR067887A1 true AR067887A1 (es) 2009-10-28

Family

ID=39884986

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103471A AR067887A1 (es) 2007-08-10 2008-08-08 Composicion medica con contenido de rebamipide

Country Status (7)

Country Link
JP (2) JP5328789B2 (es)
KR (1) KR101551506B1 (es)
CN (1) CN101778626B (es)
AR (1) AR067887A1 (es)
MY (1) MY157582A (es)
TW (1) TW200918060A (es)
WO (1) WO2009022674A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140010882A1 (en) * 2011-03-24 2014-01-09 Takakuni Matsuda Pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
JP5756727B2 (ja) * 2011-09-30 2015-07-29 ハウス食品グループ本社株式会社 顆粒
KR20140016848A (ko) * 2012-07-31 2014-02-10 가톨릭대학교 산학협력단 레바미피드를 유효성분으로 포함하는 고지혈증 및 이와 관련된 질환의 예방 또는 치료용 조성물
US20150328179A1 (en) * 2012-12-28 2015-11-19 Kao Corporation Dicaffeoylquinic acid-containing drink
JP6468919B2 (ja) * 2014-03-31 2019-02-13 富士フイルム富山化学株式会社 セファロスポリンエステルを含む粒状固形製剤
KR20170039347A (ko) * 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
US20170295834A1 (en) * 2015-11-25 2017-10-19 Alexander LaCroix All-Natural Bitterness-Reducing Flavor System
JP7057286B2 (ja) 2016-12-28 2022-04-19 富士フイルム富山化学株式会社 医薬組成物
JP7011300B2 (ja) * 2017-12-19 2022-02-10 株式会社島田製薬 ＨＭＢＣａ含有顆粒の製造方法、及びサプリメント
KR101923519B1 (ko) * 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR20230090184A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 에스오메프라졸 및 레바미피드를 포함하는 약제학적 복합제제
KR20230090185A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 위 점막 병변을 동반한 류마티스 관절염을 치료하는 약제학적 복합제제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2839847B2 (ja) * 1993-10-21 1998-12-16 大塚製薬株式会社 インターロイキン−８産生抑制剤
JPH10306038A (ja) * 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd ブロムヘキシン含有液剤
JP3466921B2 (ja) * 1998-06-03 2003-11-17 大塚製薬株式会社 味マスキング医薬製剤
JP3417857B2 (ja) * 1998-12-11 2003-06-16 日清オイリオ株式会社 調味料
KR20040104020A (ko) * 2003-06-02 2004-12-10 진양제약주식회사 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제
JP4244715B2 (ja) * 2003-06-12 2009-03-25 株式会社ノエビア 薬味飲料
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
JP2005312305A (ja) * 2004-04-27 2005-11-10 Goodoo Kasei Kk 健康剤
JP4713104B2 (ja) * 2004-08-04 2011-06-29 ファイザー株式会社 アジスロマイシン類を有効成分とする苦味が抑制された安定な組成物
JP5680815B2 (ja) * 2005-04-22 2015-03-04 焼津水産化学工業株式会社 塩化カリウム含有飲食品の製造方法、及び該製造方法によって得られた塩化カリウム含有飲食品
JP4881268B2 (ja) * 2006-09-25 2012-02-22 あすか製薬株式会社 苦味が抑制された経口製剤

Also Published As

Publication number Publication date
JP2013177418A (ja) 2013-09-09
KR20100051850A (ko) 2010-05-18
JP5328789B2 (ja) 2013-10-30
WO2009022674A1 (en) 2009-02-19
TW200918060A (en) 2009-05-01
JP2010535757A (ja) 2010-11-25
MY157582A (en) 2016-06-30
KR101551506B1 (ko) 2015-09-08
CN101778626A (zh) 2010-07-14
CN101778626B (zh) 2014-05-07

Similar Documents

Publication Publication Date Title
AR067887A1 (es) Composicion medica con contenido de rebamipide
EA201300989A1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
BR112016001950A2 (pt) Glicosídeos de esteviol
BR112012017054A2 (pt) "análogo de peptídeo de oxintomodulina, seu uso, bem como composição farmacêutica"
ECSP13012421A (es) FORMA DE DOSIFICACION FARMACEUTICA QUE COMPRENDE 6'-FLUORO-(N-METIL- O N,N-DIMETIL)-4-FENIL-4',9'-DIHIDRO-3'H-ESPIRO[CICLOHEXAN-1,1'-PIRANO[3,4,b]INDOL]-4-AMINA
AR083480A1 (es) Mezclas de stevia que contienen rebaudiosida b
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
BR112013020511A2 (pt) composição de estévia
BR112013015855A2 (pt) composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
HK1154795A1 (en) Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
UA107570C2 (xx) Безспиртовий водний розчин, що містить пропранолол
BR112012028618A2 (pt) composição edulcorantes com reduzido sabor desagradável amargo e métodos de preparo
CO6470841A2 (es) Preparación de sólido que presenta propiedad de disolución mejorada de un medicamento a partir de la misma
BR112015017251A2 (pt) composições farmacêuticas compreendendo doadores de nitroxil
MX2013011336A (es) Composiciones farmaceuticas intranasales de benzodiazepina.
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
EA201170512A1 (ru) Композиция для перорального введения
ES2425315R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria
EA201600088A1 (ru) Парентеральное введение тапентадола
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
ES2429422R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
MX2010002812A (es) Composiciones alimenticias que contienen extractos de melisa.
ECSP11010856A (es) Composición farmacéutica sólida
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
TR200900882A2 (tr) Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.

Legal Events

Date Code Title Description
FB Suspension of granting procedure